Hernandez (ID 71264) v. Corizon, Inc.

CourtDistrict Court, D. Kansas
DecidedJuly 31, 2020
Docket5:19-cv-03095
StatusUnknown

This text of Hernandez (ID 71264) v. Corizon, Inc. (Hernandez (ID 71264) v. Corizon, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Kansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Hernandez (ID 71264) v. Corizon, Inc., (D. Kan. 2020).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS

CHILO HERNANDEZ,

Plaintiff,

vs. Case No. 5:19-cv-03095-EFM-ADM

CORIZON, INC., ZIAVDDIN MONIR, and NANCY CISKEY,

Defendant.

MEMORANDUM AND ORDER

Plaintiff Chilo Hernandez has brought claims against defendants Nancy Ciskey, Ziavddin Monir, and Corizon, Inc. (“Corizon”) asserting that they violated his Eighth and Fourteenth Amendment rights and committed medical malpractice. Ciskey and Corizon have together filed a Motion for Summary Judgment (Doc. 49). Monir has separately filed his own Motion for Summary Judgment (Doc. 52). Defendants contend that Hernandez has failed to establish the subjective component of deliberate indifference to support his claim that each of them violated his Eighth Amendment rights. Ciskey and Corizon further argue that the Court should decline to exercise supplemental jurisdiction over Hernandez’s medical malpractice claims. In contrast, Monir contends that the Court should grant summary judgment to him on the medical malpractice claims because Hernandez fails to rely on expert testimony. For the reasons stated in more detail below, the Court grants both motions. I. Factual and Procedural Background1 Since May 2017, Hernandez has been incarcerated at Hutchinson Correctional Facility (“HCF”), having previously served time in custody at several other prisons. Ciskey, an APRN, and Monir, a doctor, are employees of Corizon, a medical services provider to prisoners at HCF. Hernandez has a long medical history of ulcerative colitis (“UC”), beginning in February

2011. UC is an inflammatory bowel disease which causes ulcers and bleeding, frequently resulting in bloody stools. Although UC is often dormant, changes in diet, such as eating hot and spicy foods, can worsen symptoms. Drugs commonly used to treat UC include Colazal, Canasa, Asacol, prednisone, and sulfasalazine, along with biologics Humira and Entyvio. To initially treat UC’s symptoms in 2011, Hernandez’s first doctor proscribed Colazal, a brand name version of balsalazide. Colazal is the only formulary drug in its therapeutic category. However, the doctor noted in February, April, and June of 2011 that Hernandez showed an “inadequate clinical response to therapeutic tr[ia]ls” of Colazal regarding the “[treatment] of Ulcerative Colitis.”2 In response, the doctor soon increased the amount of Colazal because

Hernandez continued to experience rectal bleeding. On top of Colazal, Hernandez was proscribed prednisone in increasing amounts between March 17, 2011 and April 19, 2012. Furthermore, Hernandez was proscribed Canasa from April 26, 2011 to May 1, 2011 and again from February 3, 2012 to February 19. Finally, the doctor proscribed Asacol from May 18, 2011 to August 18, 2012. Monir’s affidavit states that Colazal controlled Hernandez’s symptoms during this time.

1 Hernandez made many statements of fact in his Responses to Defendants’ Motions for Summary Judgment which were unsupported by any admissible evidence. According to Rule 56(c)(1)(A) of the Federal Rules of Civil Procedure, a party must support all assertions of fact with admissible evidence when opposing a motion for summary judgment. Therefore, Hernandez’s unsupported statements of fact will not be considered. 2 Doc. 53, Ex. 2, at 287–89. Hernandez tested positive for a gluten allergy on December 16, 2016. He began a gluten- free diet at some unidentified point. In February 2017, Hernandez visited a gastroenterologist, Dr. Gaston, claiming that his gluten-free diet lessened his UC symptoms. Hernandez underwent an EGD and colonoscopy which showed mild chronic inflammatory cells, even though they were inactive at the time. Dr. Gaston prescribed Colazal to control any flare ups. Shortly thereafter,

Hernandez transferred to HCF. At HCF, Hernandez again went on a gluten-free diet. However, on several occasions he bought spicy foods or other items with gluten from the prison’s canteen. Ciskey and Monir witnessed Hernandez stating that he did not eat the items, but rather traded them with other inmates. Nevertheless, both Ciskey’s and Monir’s affidavits maintain that Hernandez was noncompliant with his gluten-free diet. Hernandez failed to contradict their assertion with admissible evidence. Ciskey first saw Hernandez on September 21, 2017. Hernandez had stopped taking Colazal shortly before then, claiming it made his symptoms worse. Ciskey discontinued Hernandez’s

Colazal prescription. Despite some reported symptoms and a recent scan showing mild inflammation, Ciskey noted that Hernandez was not experiencing acute distress. Hernandez requested that Ciskey prescribe Humira or Entyvio, which Ciskey refused. She then prescribed that he continue his gluten-free diet as well as take Ensure and Protonix. After complaining of having six to eight bloody stools each day, Hernandez underwent observation for 24 hours on October 29, 2018. Here, the evidence conflicts. Monir’s affidavit asserts that Hernandez experienced no instances of bloody stools during these observations, while Ciskey’s affidavit admits one occasion of a scant amount of blood in the stool. However, the medical record cited by Hernandez indicates that he had two instances showing between 5ml–10ml reddish brown liquid in his stool. Hernandez did not complain of any pain or distress during the observation. After discharge, Monir instructed Hernandez to stick to his gluten-free diet. Ciskey saw Hernandez again on December 24, 2018. Despite his complaints of having several bloody stools each day since August of that year, Hernandez had none of the symptoms of significant blood loss, such as low hemoglobin or anemia. Ciskey prescribed prednisone for ten

days to deal with the bloody stools. On January 19, 2019, Hernandez complained that the prednisone was unhelpful and requested other medications. Ciskey then referred Hernandez to Monir. In response to Hernandez’s continuing complaints, Monir referred Hernandez to Dr. Johnson, a gastroenterologist. Dr. Johnson diagnosed him with “moderately active ulcerative colitis.”3 Dr. Johnson recommended Colazal as treatment, which Monir thereafter prescribed. However, Hernandez soon stopped taking Colazal after he complained that it made his symptoms worse. After further complaints, Hernandez underwent a 72-hour observation in March 2019 to confirm his allegations of several bloody stools each day. Monir’s and Ciskey’s affidavits claim

that no bloody stools occurred during the observation. However, the medical record states that Hernandez had “speckles of blood noted in stool” twice, as well as a “scant am[oun]t of bright red blood on toilet paper.4 Once again, Hernandez did not complain of pain or distress or exhibit signs of blood loss. At that time, Hernandez stated that his gluten free diet controlled his UC symptoms. As of November 27, 2019, Hernandez’s condition was stable, and he was not experiencing any flare-ups of his UC.

3 Doc. 53, Ex. 2, at 273. 4 Doc. 53, Ex. 2, at 206. In total, the medical staff at HCF documented Hernandez’s statements that Colazal was an ineffective treatment for Hernandez’s UC nine different times between July 7, 2017 and March 3, 2019. Hernandez claimed on different occasions that Colazal caused dizziness, difficulty concentrating, headaches, loss of balance, blackouts, and bloody stools. Throughout that time, Hernandez refused appointments and medications on multiple occasions and bought non-gluten

free items from the prison’s canteen. Hernandez commenced this action on May 20, 2019. On March 3, 2020, Hernandez served a Rule 36 request for admission to Corizon pursuant to the Federal Rules of Civil Procedure.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
Whitley v. Albers
475 U.S. 312 (Supreme Court, 1986)
Graham v. Connor
490 U.S. 386 (Supreme Court, 1989)
Adler v. Wal-Mart Stores, Inc.
144 F.3d 664 (Tenth Circuit, 1998)
Perkins v. Kansas Department of Corrections
165 F.3d 803 (Tenth Circuit, 1999)
Mapp v. Uphoff
199 F.3d 1220 (Tenth Circuit, 1999)
Mitchell v. City of Moore
218 F.3d 1190 (Tenth Circuit, 2000)
Murray v. City of Tahlequah
312 F.3d 1196 (Tenth Circuit, 2002)
Dubbs Ex Rel. Dubbs v. Head Start, Inc.
336 F.3d 1194 (Tenth Circuit, 2003)
Thom v. Bristol-Myers Squibb Co.
353 F.3d 848 (Tenth Circuit, 2003)
Lifewise Master Funding v. Telebank
374 F.3d 917 (Tenth Circuit, 2004)
Mata v. Saiz
427 F.3d 745 (Tenth Circuit, 2005)
Self v. Oliva
439 F.3d 1227 (Tenth Circuit, 2006)
Martinez v. Beggs
563 F.3d 1082 (Tenth Circuit, 2009)
Muller v. Culbertson
408 F. App'x 194 (Tenth Circuit, 2011)
Mitchell v. Maynard
80 F.3d 1433 (Tenth Circuit, 1996)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Hernandez (ID 71264) v. Corizon, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/hernandez-id-71264-v-corizon-inc-ksd-2020.